Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
作者信息
Song Kenneth, Rajvanshi Pankaj
出版信息
N Engl J Med. 2005 Oct 13;353(15):1630-1; author reply 1630-1. doi: 10.1056/NEJMc052065.
PMID:16221792
Abstract
摘要
相似文献
1
Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
N Engl J Med. 2005 Oct 13;353(15):1630-1; author reply 1630-1. doi: 10.1056/NEJMc052065.
2
Peginterferon and lamivudine for hepatitis B.
N Engl J Med. 2004 Dec 30;351(27):2879; author reply 2879. doi: 10.1056/NEJM200412303512720.
3
Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
Nat Clin Pract Gastroenterol Hepatol. 2005 Jan;2(1):12-3. doi: 10.1038/ncpgasthep0068.
4
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
N Engl J Med. 2005 Jun 30;352(26):2682-95. doi: 10.1056/NEJMoa043470.
5
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
N Engl J Med. 2004 Sep 16;351(12):1206-17. doi: 10.1056/NEJMoa040431.
6
[Interferon therapy for chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):726-9.
7
Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.
Gut. 2007 May;56(5):699-705. doi: 10.1136/gut.2005.089722. Epub 2006 Nov 24.
8
Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
N Engl J Med. 2005 Oct 13;353(15):1630-1; author reply 1630-1.
9
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
Hepatology. 2008 Feb;47(2):428-34. doi: 10.1002/hep.22065.
10
Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
Semin Liver Dis. 2004;24 Suppl 1:45-53. doi: 10.1055/s-2004-828678.
Zotero 插件